acquired
Stage
About
Symetis was a Swiss medical device company that developed transcatheter aortic valve implantation (TAVI) systems for treating aortic valve disease. The company focused on implantable heart-valve technologies for minimally invasive cardiac procedures and was later acquired.
Explore Symetis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.